Unveiling the intratumor microbiome in liver cancer: Current insights and prospective applications
Clinical and Molecular Hepatology · 01.07.2025 · 31 (3) · 685-705
DOI: 10.3350/cmh.2024.1039 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.07.2025. Verfasst von Xindi Ke und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Ch…. Hauptthemen laut MEDLINE: Liver Neoplasms, Gastrointestinal Microbiome, Microbiota. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National High Level Hospital Clinical Research Funding, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
The role of the gut microbiome in the development and progression of liver cancer has long been recognized. However, the presence of microbes in tumors that were previously considered sterile has only recently been discovered. The intratumor microbiome in liver cancer likely originates from various sources, including the gut, hematogenous spread from other mucosal locations, adjacent non-cancerous tissues, and co-metastasis with the tumor cells. As a newly discovered component of the tumor microenvironment, it regulates host immune responses, promotes chronic inflammation, modulates metabolic pathways, and exerts other influences in liver cancer. These unique features offer potential new biomarkers for liver cancer prognosis and treatment response. Exploring the complex interactions between intratumor microbiome and the host to modulate or target the intratumor microbiome may provide new avenues for liver cancer treatment. This article provides a comprehensive review of our current understanding regarding the potential origins of the intratumor microbiome in liver cancer, its unique characteristics, and the underlying mechanisms by which it affects liver cancer. Furthermore, we discuss the promising clinical implications and potential challenges that remain before this knowledge can be fully integrated into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Head and Neck Surgical Oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Oncology, Beijing You'an Hospital, Capital Medical University, Beijing, China.
- Liver Transplantation Center, National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
- Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Förderung
- National High Level Hospital Clinical Research Funding
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
- China Postdoctoral Science Foundation
- University Science Research Project of Jiangsu Province
Zitieren
APA
Ke, X., Jiang, S., Wei, Q., Sun, M., Sun, H., Pang, M., Liu, M., Sun, L., Yang, H., & Mao, Y. (2025). Unveiling the intratumor microbiome in liver cancer: Current insights and prospective applications. Clinical and Molecular Hepatology, 31(3), 685-705. https://doi.org/10.3350/cmh.2024.1039
Vancouver
Ke X, Jiang S, Wei Q, Sun M, Sun H, Pang M, et al. Unveiling the intratumor microbiome in liver cancer: Current insights and prospective applications. Clinical and Molecular Hepatology. 2025;31(3):685-705. doi:10.3350/cmh.2024.1039
BibTeX
@article{Ke2025,
author = {Ke, Xindi and Jiang, Shangze and Wei, Qiaoxin and Sun, Minghao and Sun, Hang and Pang, Mingchang and Liu, Mei and Sun, Lejia and Yang, Huayu and Mao, Yilei},
title = {Unveiling the intratumor microbiome in liver cancer: Current insights and prospective applications},
journal = {Clinical and Molecular Hepatology},
year = {2025},
volume = {31},
number = {3},
pages = {685--705},
doi = {10.3350/cmh.2024.1039}
}
EUVIMED